Medication for atherosclerosis prophylactics and therapy and for prevention of metabolic disorders

Medication for atherosclerosis prophylactics and therapy and for prevention of metabolic disorders

Activity Start Date 01.02.2016
Advantages and Innovations: The innovation aspect of the offer is the technology for synthesis of nanosized pharmaceutical preparation on the basis of plant extracts. The preparation has an improved bioavailability and reduced toxicity. The technology is environmentally friendly.
Center name: Тестовый центр
Comments Regarding IPR Status: Russia, 2012
Copyright: Patents granted
Date of creation: 01.02.2016
Description of the offer: Cardiovascular diseases and diabetes are holding the first place among the most common and dangerous diseases. Annual death rate for cardiovascular diseases makes 17 mln persons. It is known that every two men out of the three die from heart diseases, directly or indirectly related to atherosclerosis. It is also noticed that diabetic patients suffer from a more expressed atherosclerosis. Development of new medications for preventing and treating atherosclerosis and diabetes is, hence, very topical. The state-of-the-art trends in the development of novel pharmaceuticals are based on the creation of nanostructurised compositions with enhanced characteristics. A small Russian company developed an innovative nanostructurised drug, based on natural compounds, for prophylactics and therapy of cardiovascular diseases and diabetes. The profound studies carried out by the company resulted in the development of a mechano-chemical technology for synthesis of nanosized pharmaceutical composition with an improved bioavailability and reduced toxicity. On the basis of this technology, an innovative preparation is developed for prophylactics and therapy of cardiovascular diseases and diabetes. The company is looking for partners for joint research and clinical tests, with the view to further setting up a batch production of the preparation.
Market Keywords: 05003005 Drug delivery and other equipment / 05007002 Pharmaceuticals/fine chemicals
Profile type: Technology offer
Summary: A small company from Kaluga region developed an effective method for producing an innovative nanostructurised drug for prophylactics and therapy of cardiovascular diseases through mechano-chemical synthesis technologies. The company looks for partners for technical and research cooperation.
Technological Keywords: 06001002 Clinical Research, Trials / 06001011 Heart and blood circulation illnesses / 06001013 Medical Technology / Biomedical Engineering / 06001015 Pharmaceutical Products / Drugs
Type and Role of Partner Sought: R&D centre, university or a company (pharmaceutics, biotechnology, development of pharmaceuticals for treating cardio-vascular diseases) with own base for implementing a full cycle of clinical tests of the preparation Tasks to be performed: Joint research and clinical tests, with the view to further setting up a batch production of the preparation. R&D centre, university or a company (pharmaceutics, biotechnology, development of pharmaceuticals for treating cardio-vascular diseases) with own base for implementing a full cycle of clinical tests of the preparation Tasks to be performed: Joint research and clinical tests, with the view to further setting up a batch production of the preparation.
Type of Partnership Required: Research cooperation agreement / Technical cooperation agreement / Services Agreement

Back to the list

logo Республиканский фонд поддержки малого и среднего предпринимательства
logo Бизнес-инкубатор РМЭ
logo Торгово-промышленная палата РМЭ
logo Инвестиционный портал РМЭ